Prevention of Oral Malodor With an Oral Sticker Containing Herbal Formula
Invivo Study of the Efficacy of an Innovative Herbal Formula and Delivery System on Oral Malodor
1 other identifier
interventional
15
1 country
1
Brief Summary
the use of a herbal formulation containing sage, echinacea,lavender and mastic gum would prevent oral malodor if delivered in an appropriate delivery system to enable slow release of the active ingredients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started Mar 2006
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 6, 2005
CompletedFirst Posted
Study publicly available on registry
November 8, 2005
CompletedStudy Start
First participant enrolled
March 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2008
CompletedJanuary 6, 2010
October 1, 2009
1.8 years
November 6, 2005
January 5, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Oral malodor will be measured with a Halimeter monitor and an odor judge before the sticker application and following the application every 7 minutes until the odor level would reach plateau.
Interventions
Eligibility Criteria
You may qualify if:
- random gender, age and healthy people
You may not qualify if:
- used antibiotics in the last three months or suffer from systemic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hadassah Medical Organization,
Jerusalem, 91120, Israel
Related Publications (1)
Mizrahi B, Golenser J, Wolnerman JS, Domb AJ. Adhesive tablet effective for treating canker sores in humans. J Pharm Sci. 2004 Dec;93(12):2927-35. doi: 10.1002/jps.20193.
PMID: 15459950RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Perez Davidi, DMD
Hadassah Medical Organization
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 6, 2005
First Posted
November 8, 2005
Study Start
March 1, 2006
Primary Completion
January 1, 2008
Study Completion
September 1, 2008
Last Updated
January 6, 2010
Record last verified: 2009-10